Astrazeneca
LUMOXITI
Manufacturer:
Astrazeneca
Name:
LUMOXITI
HCPCS Code Descriptor:
Injection, moxetumomab pasudotox-tdfk, 0.01 mg
Category:
J Code
HCPCS:
J9313
NDC(s):
00310-4700-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
LUMOXITI is an Oncology drug manufactured by Astrazeneca and administered via the Intravenous route of administration. The J Code: J9313 is aligned to the drug LUMOXITI.
Access Pricing and More By Registering
HCPCS Added Date:
10/1/19
HCPCS Effective Date:
10/1/19
HCPCS Short Description:
Inj., lumoxiti, 0.01 mg
Billing and Coding Guide:
https://www.myaccess360.com/content/dam/website-services/us/552-access360/hcp-pdf/LUMOXITI-Coding-Resource.pdf
Patient Assistance:
https://www.myaccess360.com/home.html